drugset / Trial / NCT02251652

Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses

NCT02251652

RandomizedParallel-groupSingle-blindTreatment

Summary

Sequential therapy with cryosurgery and ingenol mebutate may optimize the treatment of hypertrophic AKs and also treat non-hypertrophic AKs in this anatomic location. Furthermore, use of ingenol mebutate will also be evaluated for potential treatment of subclinical lesions.

Timeline

Start
2013-04
Primary completion
2014-12
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator ingenol mebutate Small molecule 0.05 % Topical

Indications